Evidence map›Paper›PMID 35627101›Full record

ArticleGenes2022

Effects of Multi-Omics Characteristics on Identification of Driver Genes Using Machine Learning Algorithms.

Feng Li, Xin Chu, Lingyun Dai, Juan Wang, Jinxing Liu, Junliang Shang

Abstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feng LiSchool of Computer Science, Qufu Normal University, Rizhao 276826, China.ORCID 0000-0002-5556-3789
Xin ChuSchool of Computer Science, Qufu Normal University, Rizhao 276826, China.
Lingyun DaiSchool of Computer Science, Qufu Normal University, Rizhao 276826, China.
Juan WangSchool of Computer Science, Qufu Normal University, Rizhao 276826, China.ORCID 0000-0003-3934-0435
Jinxing LiuSchool of Computer Science, Qufu Normal University, Rizhao 276826, China.ORCID 0000-0001-6104-2149
Junliang ShangSchool of Computer Science, Qufu Normal University, Rizhao 276826, China.ORCID 0000-0002-8488-2228

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a complex disease caused by genomic and epigenetic alterations; hence, identifying meaningful cancer drivers is an important and challenging task. Most studies have detected cancer drivers with mutated traits, while few studies consider multiple omics characteristics as important factors. In this study, we present a framework to analyze the effects of multi-omics characteristics on the identification of driver genes. We utilize four machine learning algorithms within this framework to detect cancer driver genes in pan-cancer data, including 75 characteristics among 19,636 genes. The 75 features are divided into four types and analyzed using Kullback-Leibler divergence based on CGC genes and non-CGC genes. We detect cancer driver genes in two different ways. One is to detect driver genes from a single feature type, while the other is from the top N features. The first analysis denotes that the mutational features are the best characteristics. The second analysis reveals that the top 45 features are the most effective feature combinations and superior to the mutational features. The top 45 features not only contain mutational features but also three other types of features. Therefore, our study extends the detection of cancer driver genes and provides a more comprehensive understanding of cancer mechanisms.

Indexed as

Machine LearningNeoplasmsAlgorithmsGenomicsHumansOncogenesdriver geneKullback–Leibler divergencemachine learningmulti-omicspan-cancer

Identifiers

PMID35627101
PMCPMC9141966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.